The Europe Protein A Resin Market would witness market growth of 5.7% CAGR during the forecast period (2022-2028).
Protein A agarose bead is the frequently used matrix in industries or labs amidst different matrices. The agarose beads are interlinked to Protein A resin by amide bond creation. As a result, these beads have a high affinity & capacity for antibodies. Moreover, Protein A agar beads are also opposed to urea, chaotropic agents (like potassium thiocyanate & guanidine hydrochloride), and a wide pH range from 2-11.
Thus, it doesn’t get damaged or break easily even in severe elution conditions, like when detaching bound antibodies. Protein A resin has multiple applications, varying from its usage in biomanufacturing & bioprocessing assays to affinity chromatographic assays, and immunoprecipitation.
Because of its specificity, the resin is selected as a usual method to obtain antibodies in the purification procedure. Recombinant Streptococcal Protein A is the extensively used resin among all the accessible commercial proteins. It is delicate to alkaline situations and, therefore, cannot be utilized with cost-effective & rigorous NaOH and CIP-associated sanitization protocols.
The increasing population and the changes in demography will place constant stress on the UK’s system. It is estimated that approximately 26 million people have long-term health conditions. Government stats state that 63% of adults are overweight or obese. The number of people over 65 is estimated to rise from 18% in 2018 to 23.9% in 2036. With the increasing old aged population and development of well-organized and robust healthcare infrastructure, the market is predicted to grow in the Europe region.
The Germany market dominated the Europe Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $125.3 million by 2028.The UK market is anticipated to grow at a CAGR of 4.8% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 6.5% during (2022 - 2028).
Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Protein A Resin Market will Hit $1.9 Billion by 2028, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).
By Product Type
By End Use
By Type
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
